Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Best Web-based Courses for Ability Advancement - 2Five held on suspicion of planning attack on German Christmas market
- 3Mossad unveils network of Hamas terror infrastructure across Europe
- 4Winter virus season so far is not too bad, but doctors worry about suffering to come
- 5Tech Patterns: Contraptions That Will Shape What's in store
- 5 Chiefs That Changed Our Opinion on Film
- Pick Your Favored method of transportation
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- Ryan Gosling responds to Deidre Hall's invitation to visit the 'Days of Our Lives' set: 'This is a very enthusiastic yes'
- Key Little Things That Advantage Old People
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- Tourist trade in Greece and Cyprus suffering from Iran war effects
- The Meaning of Breaking the Pen's Nib in Death penalties
- Israel intensifies Lebanon attacks and hits areas not in Hezbollah's control
